May 20, 2026 | GAIA-BT
[Image] GAIA-BT Partners with Prosilico for AI-Based Drug Discovery Collaboration
On May 20th (Wednesday), GAIA-BT and Prosilico, a frontrunner in AI/M-based prediction of human clinical ADME/PK based in Sweden, signed a letter of intent to kick-off a collaborative partnership for the further development of AI-based drug discovery.
